TY  - RPRT
TI  - A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccines
AU  - Wang, H.
AU  - Wu, X.
AU  - Zhang, Y.
AU  - Chen, Q.
AU  - Dai, L.
AU  - Chen, Y.
AU  - Liu, X.
PY  - 2021
DO  - 10.1101/2021.07.13.452194
UR  - https://www.biorxiv.org/content/10.1101/2021.07.13.452194v1
ID  - 10.1101/2021.07.13.452194
ER  -